Amplifon

Digital Transformation And Aging Demographics Will Drive Global Success

AnalystHighTarget

Not Invested

Consensus Narrative from 15 Analysts

Published

24 Aug 25

Updated

24 Aug 25

AnalystHighTarget's Fair Value

€25.00

36.9% undervalued

24 Aug

€15.78

-45.8%

3.2%

-45.8%

3.2%

Author's Valuation

€25.0

36.9% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

€25.0

36.9% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

5.74%

Healthcare Services revenue growth rate

0.26%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

8.83%

Calculation

€276.73m

Earnings '28

25.03x

PE Ratio '28

€6.93b

Market Cap '28

€6.93b

Market Cap '28

215.10m

No. shares '28

€32.21

Share Price '28

€32.21 Share Price '28

Discounted to 2025 @ 8.83% p.a.

€24.99

Fair Value '25